AJ
Arjunsingh Jyotsingh Chavan
About Arjunsingh Jyotsingh Chavan
Data last updated:
Arjunsingh Jyotsingh Chavan is a Director at Sejon Pharma Private Limited (since 2020) and Director at John Mark Pharmaceuticals Limited (since 2022). The companies operate in Trading. The largest current company by reported revenue is Sejon Pharma Private Limited at ₹13.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jul 2020 | 2020 | ₹13.2 Lakh (FY 2023) | Active | |
| Director | 09 Dec 2022 | 2022 | Active |
Board colleagues of Arjunsingh Jyotsingh Chavan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Krishna Jyotsingh Chauvhan | 08801661 | Sejon Pharma Private Limited | Director |
| Dinesh Pralhadsing Rajput | 09818244 | John Mark Pharmaceuticals Limited | Director |
| Mayur Pramod Panjabi | 10783155 | John Mark Pharmaceuticals Limited | Director |
| Ravindra Utreshwar Ghumbre | 09818245 | John Mark Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arjunsingh Jyotsingh Chavan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arjunsingh Jyotsingh Chavan
Arjunsingh Jyotsingh Chavan currently holds 2 directorships: Sejon Pharma Private Limited (Director, since 20 Jul 2020, revenue ₹13.2 Lakh (FY 2023)); John Mark Pharmaceuticals Limited (Director, since 09 Dec 2022).
Arjunsingh Jyotsingh Chavan was first appointed on 20 Jul 2020 as Director at Sejon Pharma Private Limited. The most recent appointment on record is 09 Dec 2022 at John Mark Pharmaceuticals Limited.
The current boards of Arjunsingh Jyotsingh Chavan's companies include Krishna Jyotsingh Chauvhan (Sejon Pharma Private Limited), Dinesh Pralhadsing Rajput (John Mark Pharmaceuticals Limited), Mayur Pramod Panjabi (John Mark Pharmaceuticals Limited), Ravindra Utreshwar Ghumbre (John Mark Pharmaceuticals Limited).